(Q85001511)
Statements
Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists (English)
Wolfgang Gaissmaier
Christoph Heesen
Ingo Kleiter
Franziska Nguyen
Nina Schäffler
Jürgen Kasper
8 September 2010